Clinical & translational oncology

• 

  Año 2023, Vol. 25, Número 6

  • REVIEW ARTICLE

    • Non-coding RNAs as potential biomarkers of gallbladder cancer

      Yan Lv, Wanyue Yin, Zhikai Zhang

      • Resumen

      págs. 1489-1511

      

    • A novel regulator in cancer initiation and progression: long noncoding RNA SHNG9

      Mingxing Zhao, Yang Zhang, Shen Shen

      • Resumen

      págs. 1512-1521

      

    • Lactobacillus for ribosome peptide editing cancer

      Shousong Yue, Qiuxia He, Jean François Picimbon

      • Resumen

      págs. 1522-1544

      

    • The stimulator of interferon genes (STING) agonists for treating acute myeloid leukemia (AML): current knowledge and future outlook

      Xiaolu Song, Ye Peng, Xiaogang Wang, Qi Chen, Xinyu Lan, Fangfang Shi

      • Resumen

      págs. 1545-1553

      

    • Bcl-2 pathway inhibition in solid tumors: a review of clinical trials

      Ioanna Ploumaki, Efthymios Triantafyllou, Ioannis Alexios Koumprentziotis, Konstantinos Karampinos, Konstantinos Drougkas, Ioannis Karavolias, I. P. Trontzas, E. Kotteas

      • Resumen

      págs. 1554-1578

      

    • Tumor immune microenvironment components and the other markers can predict the efficacy of neoadjuvant chemotherapy for breast cancer

      Weiqian Zhang, Ke Xu, Zhengfa Li, Linwei Wang, Honglei Chen

      • Resumen

      págs. 1579-1593

      

    • Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview

      Evelina Charidemou, Costas Koufaris, Maria Louca, Antonis Kirmizis, Teresa Rubio Tomás

      • Resumen

      págs. 1594-1605

      

  • RESEARCH ARTICLE

    • Cancer-associated fibroblasts contribute to cancer metastasis and apoptosis resistance in human ovarian cancer via paracrine SDF-1α

      Jie-min Dai, Ke Sun, Chang Li, Min Cheng, Jun-hua Guan, Li-na Yang, Li-wen Zhang

      • Resumen

      págs. 1606-1616

      

    • Identification of a cuproptosis-related lncRNA prognostic signature in lung adenocarcinoma

      Ran Chen, Haichao Luo, Qitian Chen, Changying Wang

      • Resumen

      págs. 1617-1628

      

    • Role of synaptotagmin 13 (SYT13) in promoting breast cancer and signaling pathways

      Yi-Dan Zhang, Rui Zhong, Jin-Quan Liu, Zhen-Xuan Sun, Teng Wang, Jin-Tao Liu

      • Resumen

      págs. 1629-1640

      

    • HIF-1α contributes to metastasis in choriocarcinoma by regulating DEC1 expression

      Yihui Xu, Bao Ren, Min Wang

      • Resumen

      págs. 1641-1649

      

    • LncRNA HOTAIR enhances RCC2 to accelerate cervical cancer progression by sponging miR-331-3p

      Gulimire Buranjiang, Ailikemu Abuduwanke, Xiaowen Li, Guzalinuer Abulizi

      • Resumen

      págs. 1650-1660

      

    • Prediction model of colorectal cancer (CRC) lymph node metastasis based on intestinal bacteria

      Wu Yinhang, Zhuang Jing, Zhou Jie, Jin Yin, Wu Xinyue, Song Yifei, Fan Zhiqing, Wu Wei, Han Shuwen

      • Resumen

      págs. 1661-1672

      

    • The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer

      Wei Wang, Tingting Zhu, Hao Chen, Yongzhong Yao

      • Resumen

      págs. 1673-1681

      

    • HSF1 expression in tumor-associated macrophages promotes tumor cell proliferation and indicates poor prognosis in esophageal squamous cell carcinoma

      Yiqiu Li, Qifan Li, Jiasheng Liu, Yuying Huang, Jinzhu Mao, Ge Zhang

      • Resumen

      págs. 1682-1689

      

    • CircZNF236 facilitates malignant progression in oral squamous cell carcinoma by sequestering miR-145-5p

      Qing Lu, Hongze Che, Yanhai Che, Min Hu

      • Resumen

      págs. 1690-1701

      

    • Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1/S phase

      Marzieh Rahimi Lifshagerd, Fatemeh Safari

      • Resumen

      págs. 1702-1709

      

    • Peri-osteosarcoma adipose computed tomography attenuation and volume for predicting chemotherapy response in pediatric patients

      Dong Fu

      • Resumen

      págs. 1710-1718

      

    • A novel prognostic model of methylation-associated genes in acute myeloid leukemia

      Meiyu Chen, Zhao Zeng, Wei Qin, Xiaohui Cai, Xuzhang Lu, Suning Chen

      • Resumen

      págs. 1719-1728

      

    • Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review

      Asma Khorshid Shamshiri, Maryam Alidoust, Mahboubeh Hemmati Nokandei, Alireza Pasdar, Fahimeh Afzaljavan

      • Resumen

      págs. 1729-1747

      

    • Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2‑late vaginal complications in 3D‑vaginal‑cuff brachytherapy (interventional radiotherapy)?

      Yaowen Zhang, Faegheh Noorian, Rosa Maria Abellana Sangrà, J. Rochera, Antonio Herreros, Gabriela Antelo, V. Lancellotta, L. Tagliaferri, Qian Han, Aureli Torné Bladé, Angeles Rovirosa Casino

      • Resumen

      págs. 1748-1755

      

    • Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness

      Héctor Pérez Montero, Alicia Lozano, Rodolfo De Blas Piñol, Juan José Sánchez Fernández, Evelyn Martínez Pérez, Maria Laplana, Juan Miguel Gil Gil, María Amparo García Tejedor, Sonia Pernas Simon, Catalina Falo Zamora, Oscar Godino, María Jesús Plà Farnós, Ferrán Guedea Edo, Arturo Navarro Martín

      • Resumen

      págs. 1756-1766

      

    • Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma

      Wen Rao, Lujie Yang, Nan Dai, Liang Zhang, Jie Liu, Bo Yang, Mengxia Li, Jinlu Shan, Qiushi Wang, Dong Wang

      • Resumen

      págs. 1767-1778

      

    • Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study

      Wenjing Liang, Langman Li, Miao Wang, Yixin Liu, Ye Qiu, Boyu Zhang, Qiuji Wu, Yongchang Wei

      • Resumen

      págs. 1779-1792

      

    • Epigenetic inhibition of lncRNA GMDS-AS1 by methyltransferase ESET promoted cell viability and metastasis of hepatocellular carcinoma

      Junling Huang, Tengmeng Zhong, Guangzhi Li, Shuzhen Wang, Rujuan Qin

      • Resumen

      págs. 1793-1804

      

    • Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML

      Jun-Dan Wang, Jue-Qiong Xu, Zi-Jie Long, Jian-Yu Weng

      • Resumen

      págs. 1805-1820

      

    • Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China

      Zhijuan Lin, Jie Zha, Shuhua Yi, Zhifeng Li, Lingyan Ping, Xiaohua He, Liyuan Fan, Haifeng Yu, Zhong Zheng, Wei Xu, Feili Chen, Ying Xie, Biyun Chen, Huilai Zhang, Li Wang, Kaiyang Ding, Wenyu Li, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu

      • Resumen

      págs. 1821-1829

      

    • The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis

      Yalan Sun, Ying Wang, Fang Lu, Xianghong Zhao, Zhenlin Nie, Bangshun He

      • Resumen

      págs. 1830-1843

      

    • Metabolic heterogeneity in early-stage lung adenocarcinoma revealed by RNA-seq and scRNA-seq

      Yang Zhang, Jiang Shi, Junfang Luo, Cong Liu, Lixu Zhu

      • Resumen

      págs. 1844-1855

      

    • Bioinformatic analysis of single-cell RNA sequencing dataset dissects cellular heterogeneity of triple-negative breast cancer in transcriptional profile, splicing event and crosstalk network

      Jin Qiu, Lu Ma, Tingting Wang, Juntong Chen, Dongmei Wang, Yuhan Guo, Yin Li, Xinran Ma, Geng Chen, Ying Luo, Xinghua Cheng, Lingyan Xu

      • Resumen

      págs. 1856-1868